Cellebrite
- Market cap
- 2.82B
- P/E (TTM)i
- 48.80
- P/Bi
- 5.24
- EPSi
- 0.31
- Div yieldi
- 0.00%
- 52W posi
- 16%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.4 percentage points.
Institutional ownership
- Held by institutions
- 94.26% +0.36pp
- Institutions
- 254 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2025-12-31
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 10 buys · 17 sells
| Name | Role | Stake |
|---|---|---|
| Adam Clammer | Independent External Director | 0.33% |
| Thomas Hogan | Executive Chairperson | 0.31% |
| Christopher Wade | Chief Technology Officer | 0.24% |
| David Barter | Chief Financial Officer | 0.13% |
| Ronnen Armon | Chief Products & Technologies Officer | 0.11% |
| Zohar Tadmor-Eilat | Chief Human Resources Officer | 0.05% |
| Marcus Jewell | Global Chief Revenue Officer | 0.05% |
| Holly Windham | Chief Compliance Officer | 0.04% |
| Sigalit Shavit | Chief Information Officer | 0.03% |
| Yonatan Domnitz | Independent Director | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-23 | Shiven Ramji | President of Products & Technology | Other Acquisition | +38,505 | -- |
| 2026-09-16 | Dafna Gruber | Independent External Director | Other Acquisition | +15,190 | -- |
| 2026-09-16 | Adam Clammer | Independent External Director | Other Acquisition | +15,190 | -- |
| 2026-09-16 | Troy Richardson | Director | Other Acquisition | +15,190 | -- |
| 2026-09-16 | Brandon Van Buren | Director | Other Acquisition | +15,190 | -- |
| 2026-09-16 | Nadine Baudot-Trajtenberg | Independent External Director | Other Acquisition | +15,190 | -- |
| 2026-09-16 | Yonatan Domnitz | Independent Director | Other Acquisition | +15,190 | -- |
| 2026-09-16 | Ryusuke Utsumi | Independent Director | Other Acquisition | +15,190 | -- |
| 2026-08-24 | Thomas Hogan | Executive Chairperson | Open Market Disposition | -25,299 | $11.29 |
| 2026-08-23 | David Gee | Chief Marketing Officer | Automatic Disposition | -4,323 | $11.36 |
| 2026-08-20 | David Gee | Chief Marketing Officer | Open Market Disposition | -2,198 | $11.24 |
| 2026-08-20 | Marcus Jewell | Global Chief Revenue Officer | Open Market Disposition | -12,562 | $11.24 |
| 2026-08-11 | Thomas Hogan | Executive Chairperson | Open Market Disposition | -139,713 | $15.39 |
| 2026-08-11 | David Gee | Chief Marketing Officer | Open Market Disposition | -230 | $16.07 |
| 2026-08-11 | Marcus Jewell | Global Chief Revenue Officer | Open Market Disposition | -411 | $16.07 |
| 2026-08-10 | Thomas Hogan | Executive Chairperson | Other Acquisition | +339,484 | -- |
| 2026-07-07 | David Barter | Chief Financial Officer | Open Market Disposition | -41,734 | $16.38 |
| 2026-07-05 | Ronnen Armon | Chief Products & Technologies Officer | Intent to Sell (Form 144) | -29,330 | $16.43 |
| 2026-07-01 | Thomas Hogan | Executive Chairperson | Open Market Disposition | -103,188 | $15.76 |
| 2026-06-30 | Ronnen Armon | Chief Products & Technologies Officer | Intent to Sell (Form 144) | -43,983 | $15.40 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 06:56:53 · For reference only, not investment advice and not tailored to your situation.